Evaluating the effects of nicotine concentration on the appeal and nicotine delivery of oral nicotine pouches among rural and Appalachian adults who smoke cigarettes: A randomized cross-over study

被引:8
|
作者
Keller-Hamilton, Brittney [1 ,2 ,5 ]
Alalwan, Mahmood A. [2 ]
Curran, Hayley [2 ]
Hinton, Alice [2 ,3 ]
Long, Lauren [2 ]
Chrzan, Kirsten [2 ,3 ]
Wagener, Theodore L. [1 ,2 ]
Atkinson, Leanne [2 ,3 ]
Suraapaneni, Sriya [2 ,4 ]
Mays, Darren [2 ]
机构
[1] Ohio State Univ, Coll Med, Columbus, OH USA
[2] Ohio State Univ, Ctr Tobacco Res, Comprehens Canc Ctr, Columbus, OH USA
[3] Ohio State Univ, Coll Publ Hlth, Columbus, OH USA
[4] Ohio State Univ, Coll Arts & Sci, Columbus, OH USA
[5] Ohio State Univ, Comprehens Canc Ctr, Ctr Tobacco Res, 3650 Olentangy River Rd, Columbus, OH 43214 USA
基金
美国国家卫生研究院;
关键词
Cigarettes; health disparities; misuse liability; nicotine; oral nicotine pouches; rural; TOBACCO PRODUCTS; CANCER INCIDENCE; MORTALITY;
D O I
10.1111/add.16355
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background and aims: Oral nicotine pouches (ONPs) probably offer reduced harm compared with cigarettes, but independent data concerning their misuse liability are lacking. We compared nicotine delivery and craving relief from ONPs with different nicotine concentrations to cigarettes.Design: This was a single-blind, three-visit (>= 48-hour washout), randomized-cross-over study. Participants were encouraged to complete all study visits in less than 1 month.Setting: The study took place in Rural/Appalachian Ohio.Participants: Participants comprised 30 adults who smoke cigarettes. Participants (mean(age) = 34.5) were 60% men and 90% White.Intervention: Participants who were >= 12-hour tobacco-abstinent used: (1) a 3-mg nicotine concentration ONP, (2) a 6-mg nicotine concentration ONP and (3) usual brand cigarette in separate visits. ONPs (wintergreen Zyn) were used for 30 minutes; cigarettes were puffed every 30 sec for 5 minutes.Measurements: Plasma nicotine and self-reported craving were assessed at t = 0, 5, 15, 30, 60 and 90 minutes. The primary outcome was plasma nicotine concentration at t = 30 minutes. A secondary outcome was craving relief at t = 5 minutes.Findings: At t = 30, mean [95% confidence interval (CI)] plasma nicotine was 9.5 ng/ml (95% CI = 7.1, 11.9 ng/ml) for the 3 mg nicotine ONP, 17.5 ng/ml (95% CI = 13.7, 21.3) for the 6 mg nicotine ONP and 11.4 ng/ml (95% CI = 9.2, 13.6 ng/ml) for the cigarette. Mean plasma nicotine at t = 30 minutes differed between the 3- and 6-mg nicotine ONPs (P = 0.001) and between the 6-mg nicotine ONP and cigarette (P = 0.002). Mean (95% CI) craving at t = 5 minutes was lower for the cigarette (mean = 1.00, 95% CI = 0.61, 1.39) than either the 3 mg (mean = 2.25, 95% CI = 1.68, 2.82; P < 0.0001) or 6 mg nicotine (mean = 2.19, 95% CI = 1.60, 2.79; P < 0.0001) ONP.Conclusions: Among adult smokers, using 6-mg nicotine concentration oral nicotine pouches (ONPs) was associated with greater plasma nicotine delivery at 30 minutes than 3-mg ONPs or cigarettes, but neither ONP relieved craving symptoms at 5 minutes as strongly as a cigarette. Accelerating the speed of nicotine delivery in ONPs might increase their misuse liability relative to cigarettes.
引用
收藏
页码:464 / 475
页数:12
相关论文
共 43 条
  • [21] Effects of "Tobacco Free" Language in Warning Labels on Perceptions of Electronic Cigarettes and Nicotine Pouches among Young Adult Men: A Randomized Trial
    Keller-Hamilton, Brittney
    Curran, Hayley
    Stevens, Elise M.
    Zettler, Patricia J.
    Mays, Darren
    Ferketich, Amy K.
    SUBSTANCE USE & MISUSE, 2023, 58 (10) : 1302 - 1306
  • [22] Experimentation and correlates of electronic nicotine delivery system (electronic cigarettes) among university students - A cross sectional study
    Awan, K. H.
    SAUDI DENTAL JOURNAL, 2016, 28 (02) : 91 - 95
  • [23] Trying is believing: A pilot study of in-vivo nicotine replacement therapy sampling in disadvantaged Black adults who smoke cigarettes
    Liu, Melissa A.
    Brett, Emma I.
    Chavarria, Jesus
    King, Andrea C.
    DRUG AND ALCOHOL DEPENDENCE, 2022, 241
  • [24] No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: Results of a randomized placebo-controlled cross-over study
    Vleggaar, FP
    van Buuren, HR
    Henegouwen, GPVB
    Hop, WCJ
    van Erpecum, KJ
    JOURNAL OF HEPATOLOGY, 2000, 32 : 131 - 131
  • [25] No beneficial effects of transdermal nicotine in primary sclerosing cholangitis (PSC): Results of a randomized double-blind cross-over study
    Vleggaar, FP
    Van Buuren, HR
    Henegouwen, GPV
    Van Erpecum, KJ
    HEPATOLOGY, 1999, 30 (04) : 563A - 563A
  • [26] Assessment of abuse liability and switching potential of menthol-flavored pod-based electronic nicotine delivery systems among US adults who smoke cigarettes
    Goldenson, Nicholas I.
    Shiffman, Saul
    Sembower, Mark A.
    Black, Ryan A.
    DRUG AND ALCOHOL DEPENDENCE, 2024, 258
  • [27] Nicotine beliefs and perceptions of low nicotine labels and mitigating statements among people who do and do not smoke: a cross-sectional study from Aotearoa New Zealand
    Gendall, Philip
    Popova, Lucy
    Thrasher, James
    Hoek, Janet
    TOBACCO CONTROL, 2024,
  • [28] A discrete choice experiment on price and flavour effects on the appeal of nicotine products: a pilot study among young adults in Switzerland
    Merz, Larissa
    Puhan, Milo A.
    Serra-Burriel, Miquel
    SWISS MEDICAL WEEKLY, 2024, 154
  • [29] A Randomized, Controlled Study to Assess Changes in Biomarkers of Exposures Among Adults Who Smoke That Switch to Oral Nicotine Pouch Products Relative to Continuing Smoking or Stopping All Tobacco Use
    Rensch, Jesse
    Edmiston, Jeffery
    Wang, Jingzhu
    Jin, Xiaohong
    Sarkar, Mohamadi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (10): : 1108 - 1118
  • [30] A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers
    Grant O’Connell
    John D. Pritchard
    Chris Prue
    Joseph Thompson
    Thomas Verron
    Donald Graff
    Tanvir Walele
    Internal and Emergency Medicine, 2019, 14 : 853 - 861